Background: Estimated numbers of men who have sex with men
P ublic health planners, policy makers, and workers could gain insight into primary and secondary HIV prevention and issues concerning access to or acceptance of quality care and case management through an understanding of the racial/ ethnic-specific burden and impact of HIV/AIDS mortality on men who have sex with men (MSM). The effective targeting of resources for HIV/AIDS prevention and treatment programs could benefit from knowledge of the population size, behavioral characteristics, and mortality experience of those at most increased risk for HIV by race/ethnicity. The population sizes of MSM have been previously estimated; however, the models on which these estimates have been based have tended to be complex and/or costly to apply, and apparently have been utilized by few planning agencies. [1] [2] [3] [4] [5] [6] [7] Surveys to measure the occurrence of male-male sexual contact have often resulted in underestimates, largely because of stigmatization and concealment of risk behaviors that might be considered immoral by society. 1, [8] [9] [10] In 2005, the Miami metropolitan statistical area (MSA) (Miami-Dade County, FL) had the highest reported AIDS case rate (52.8 per 100,000 population) among MSAs with $500,000 population in the United States. 11 According to the Florida Department of Health (FDOH) HIV/AIDS Reporting System, there were more than 20,000 persons living with HIV/AIDS (PLWHAs) aged $18 years through 2005 (reported cases), of whom approximately 45% were classified in the HIV exposure category of MSM. Of these PLWHAs classified as MSM, 23% were non-Hispanic white (referred to as white), 24% were non-Hispanic black (black), 52% were Hispanic (might be of any race), and 1% were of other race/ethnicity or multiracial. Among the Miami MSA's overall male population aged $18 years (N = 860,941), 18% are white, 20% are black, 60% are Hispanic, and 2% are of other race/ethnicity or multiracial (FDOH midyear population estimate, 2005). Little is known about the population sizes of the subgroups of white, black, and Hispanic MSM, however. Consequently, little is known about the MSM populationbased impact of mortality on the respective cohorts of MSM.
Several studies have developed MSM population estimates for urban areas. 3, 6, 12 The estimation of plausible numbers of white, black, and Hispanic MSM in a specific MSA has not been previously attempted, so far as we know, nor have there been any racial/ethnic-specific estimates of mortality rates among MSM with HIV/AIDS using estimated MSM populations as denominators. In this report, we apply an existing estimation model 13 to HIV/AIDS surveillance data and population data for the Miami MSA to arrive at estimates concerning racial/ethnic subpopulations of MSM and their mortality experience. The methodology has the advantages of being transparent and inexpensive to implement, relying on available data from a few sources, and being adaptable to other MSAs.
METHODS
The Centers for Disease Control and Prevention (CDC) HIV/AIDS surveillance classification scheme for HIV behavioral risk factors encompasses risk behaviors that have occurred since 1978.
14 Accordingly, we defined MSM as all men aged $18 years who had male-male sex contact since 1978, including MSM who had a history of injection drug use. We defined all other men with HIV/AIDS as injection drug users (IDUs) or high-risk heterosexuals (ie, men who had sexual contact with a woman known to be HIV-infected or at high risk for HIV infection [eg, history of injection drug use]). 15 Men in the general population who were not MSM and who do not have HIV/AIDS may or may not have a behavioral risk factor for HIV that meets these criteria.
Estimates of the Numbers of MSM and Other Men
The MSM population estimates were based on methods previously described. 13 Briefly, the average annual estimated number of HIV-infected MSM living and residing in the 
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Imputation of Risk
Risk information was generally obtained by FDOH staff from medical records and publicly funded HIV testing sites. PLWHAs in the Miami MSA who had been reported with no identified risk for HIV (NIRs) were redistributed into recognized risk groups based on expected results of followup investigations. This imputation procedure was modified from a procedure developed by Green 17 and has been previously described. 13 Sensitivity analysis was conducted to assess the effect of varying these patterns.
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Estimates of Mortality Rates and Rate Ratios Among Men With HIV/AIDS
Estimated average annual racial/ethnic-specific mortality rates among MSM with HIV/AIDS for 2003 to 2005 were calculated by dividing the average annual number of deaths among MSM HIV/AIDS cases by the average annual estimated populations of MSM in each group. The rates were similarly calculated for other men with HIV/AIDS. Rate ratios (RRs) for blacks versus whites and Hispanics versus whites were computed for the MSM and other male HIV/AIDS cases.
Varying the MSM HIV Positivity Rates and the Effect on Subsequent Estimates
As part of a sensitivity analysis, a plausible range (tantamount to an 80% confidence interval [CI]) was calculated around the point-estimate HIV seropositivity rates for the Miami MSA to determine the effect of widely varying these seropositivity rates on the mortality rates and RRs. The decision to set the CIs of the HIV seropositivity rates at 80% was intended to convey a sense that there was a broad range of possible random variation and/or bias in the MSM seropositivity rate estimates and a high probability that the true value would fall within this broad range.
The institutional review boards of the various institutions with whom the authors of the report were affiliated considered the research exempt from formal review.
RESULTS
Estimates of Numbers of MSM
The estimated average total number of MSM aged $18 years in the Miami MSA for 2003 to 2005 was 63,020 (Table  1) , or 7.5% of the annual average combined male population of whites, blacks, and Hispanics aged $18 years (N = 843,722). Table 1 were classified as MSM and 557 (42.5%) as other men ( Table  2 ). The age range of the men who died was 18 to 96 years; the age range of the subset of MSM who died was 23 to 81 years. The distributions by age at death among white, black, and Hispanic MSM did not differ significantly, nor did those among the other men (data not shown). The median age at death ranged from 44 to 48 years for all risk and racial/ethnic subgroups.
Estimated Mortality Rates
Average annual point-estimate mortality rates among men with HIV/AIDS corresponding to the point-estimate NHBS HIV seropositivity rates among MSM by race/ethnicity ( Table 3) 
Sensitivity Analysis 1
The first sensitivity analysis considered the effect of widely varying the NHBS HIV seropositivity rates. Differences in mortality rates among the racial/ethnic groups of MSM and other men with HIV/AIDS at the midpoint and lower and upper ends of the plausible ranges (see Table 3 ) remained statistically significant (all comparisons, P , 0.01).
Sensitivity Analysis 2 and Estimated Mortality Rate Ratios
Point-estimate mortality RRs were calculated (Table 4) . To assess the plausibility of the RR point estimates, minimum and maximum RRs were determined in a second sensitivity analysis. Although the point-estimate NHBS HIV seropositivity rates for MSM did not differ significantly from each other, many of the estimated mortality RRs did. Among MSM with HIV/AIDS, the mortality RR for blacks-to-whites ranged from 1.51 (P , 0.05) to 6.82 (P , 0.01) (point estimate = 3.20; P , 0.01), and for Hispanics-to-whites, the RR ranged from 0.90 (not significant; P $ 0.05) to 3.01 (P , 0.01) (point MSM include those with a joint risk factor of MSM and injection drug use. *Cases of PLWHAs aged $18 years at time of diagnosis, with those cases reported without an HIV risk factor redistributed into categories for specified risk factors based on expected results of follow-up investigations.
†HIV seropositivity rates from the NHBS project, Miami MSA, 2004 to 2005. ‡Distribution of the overall average annual Miami MSA male population aged $18 years, by race/ethnicity, is 18% white, 20% black, 60% Hispanic, and 2% other race/ethnicity or multiracial. estimate = 1.57; P , 0.01). Among the other men with HIV/AIDS, black-to-white RRs were elevated for all mortality rates corresponding to the midpoint and lower and upper ends of the plausible ranges of the HIV seropositivity rates (all comparisons, P , 0.01); the Hispanic-to-white RRs were not significant (P $ 0.05).
Sensitivity Analysis 3
We examined the possibility that black male PLWHAs were more likely than white and Hispanic male PLWHAs to be misclassified as not being MSM. We altered the redistribution fraction for blacks such that there were as many as 20% more black MSM PLWHAs than initially computed. Because this affected the percentage distribution of MSM PLWHAs by race/ethnicity, it affected all subsequent estimates of HIV prevalence (k) and the numbers of MSM (a). Specifically, the estimated number of white MSM decreased 4.0%, from 16,725 to 16,056, whereas the number of black MSM increased 14.8%, from 12,362 to 14, 192 , and the number of Hispanic MSM decreased 4.9%, from 33,932 to 32,269. These differences seemed to be tolerable. Consequently, the estimated HIV/AIDS mortality rates changed, and the pointestimate RR for black MSM/white MSM became 2.4:1 (P , 0.01 [formerly 3.2:1; P , 0.01]), whereas that for other black men/other white men became 15.7:1 (P , 0.01 [formerly 17.3:1; P , 0.01]). These reasonably tolerable differences also seemed to support the plausibility of the initial estimates. MSM include those with a joint risk factor of MSM and injection drug use. *Cases of men with HIV/AIDS aged $8 years at time of diagnosis, with those cases reported without an HIV risk factor redistributed into categories for specified risk factors based on expected results of follow-up investigations.
†Plausible range is equal to an 80% CI (see text). MSM include those with a joint risk factor of MSM and injection drug use. *Cases of men with HIV/AIDS aged $18 years at time of diagnosis, with those cases reported without an HIV risk factor redistributed into categories for specified risk factors based on expected results of follow-up investigations.
†Total excludes 15 deaths among multiracial men.
initiatives. In turn, combining these estimates with data on deaths among MSM with HIV/AIDS can result in more accurate estimates of mortality rates, which could reflect the need for enhancement of HIV diagnostic, linkage-to-care, treatment, and case management services, including the promotion of treatment adherence, to reduce mortality. Other studies that looked at MSM HIV/AIDS mortality rates have acknowledged that their rates might be underestimates because of the use of the general male population as denominators. 18, 19 HIV-infected black MSM in the Miami MSA seem to be at significantly greater risk of dying than their white counterparts, with more than a 3-fold greater point-estimate mortality rate. This is consistent with findings from an analysis of national surveillance data, which found highest death rates for black MSM with AIDS and lower survival among black MSM compared with white and Hispanic MSM with AIDS. 19 In our study, the point-estimate mortality rate among HIVinfected Hispanic MSM was also significantly elevated above that for white MSM (RR = 1.57). The NHBS findings indicated there were no statistically significant differences in racial/ethnic HIV seropositivity rates, however. Thus, we cannot assess the extent to which the observed mortality rate differentials might be explained by the HIV seropositivity rates.
Evidence suggests that black MSM tend to be diagnosed relatively late with HIV [20] [21] [22] and/or may be relatively less likely to seek or have access to quality care and treatment than white MSM, [23] [24] [25] thus putting them at increased risk for progressing to AIDS and death. In the NHBS for MSM conducted in 5 cities in 2004 to 2005, black MSM had the highest proportion of unrecognized HIV infection. 20 The combined stigma of being an MSM, belonging to a racial minority group, and being at risk for or having HIV/AIDS may contribute to delayed screening and treatment. 26, 27 Preexisting stigma experienced by MSM can be layered on top of HIV/AIDS stigma. 28 In a study, young PLWHAs who were MSM with HIV symptoms or an AIDS diagnosis felt more stigma than their heterosexual counterparts. 29 Other contributing, underlying factors could include the amount of HIV already in the community, cultural taboos and homophobia, non-HIV STIs in the community, incarceration, and many complex factors related to socioeconomic status. Such factors could partly explain our observed differentials in the racial/ethnic mortality experience.
Estimated mortality rates were far higher among each racial/ethnic group for the MSM with HIV/AIDS than for the other men with HIV/AIDS. In part, this reflects their different population compositions and behavioral risk profiles (ie, there are far greater numbers of other men in the community [denominators] , and many of them might have no behavioral risk factor for HIV). Clearly, there are individual MSM in the community who are also at no elevated risk for HIV; however, as a group, all those with a history of male-male sexual contact are considered at increased risk according to CDC convention. 30 Our point estimate of the percentage of the adult male population who are MSM (7.5%) is aligned with several other such estimates. Estimates derived from random sampling indicate that as many as 9% of adult men in large urban areas might be MSM; the corresponding percentages were 4% in suburban areas and 1% in rural areas. 12 Another report, using the same estimation model that was adopted for this article, indicated that approximately 9.5% of all adult men in the Miami MSA might be MSM; 13 however, this finding is apparently an overestimate, based on an apparent underestimate of the overall MSM HIV seropositivity rate (17.0%) compared with the current NHBS overall HIV seropositivity rate (20.0%) (see Table 1 ). Approximately 7% of men in the United States aged $19 years might be MSM according to estimates based on national survey data. 5 There are a number of limitations to our study, as with most modeled estimation studies. There is no ''gold standard'' for estimating the numbers of MSM by race/ethnicity. There are multiple uncertainties about the various parameters used to develop our estimates, including the extrapolation of HIV prevalence estimates, the imputation of risk, 31 and the representativeness of the NHBS sample of MSM and their HIV seropositivity rates. Our method of extrapolating local HIV prevalence estimates of at-risk populations from national HIV prevalence estimates has previously helped to produce plausible estimates of at-risk populations. 13, 32 The procedure may be regarded as somewhat crude, however. In particular, we have no reliable data to help us set limits on and conduct sensitivity analyses for certain parameters that could affect the accuracy of these extrapolations (eg, differences in relative completeness of reporting among the various surveillance systems and differences in rates of incidence, diagnosis, or treatment for AIDS cases and HIV [not AIDS] cases in the United States, Florida, and the Miami MSA). Different diagnosis or reporting patterns could affect the estimates of HIV prevalence but would not affect the relative rankings of MSM include those with a joint risk factor of MSM and injection drug use. *Case of men with HIV/AIDS aged $18 years at time of diagnosis, with those cases reported without an HIV risk factor redistributed into categories for specified risk factors based on expected results of follow-up investigations.
†P , 0.01; ‡P , 0.05.
